Search details
1.
First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population.
Future Oncol
; 18(20): 2521-2532, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35579260
2.
Real-world outcomes associated with liposomal irinotecan dose reductions in metastatic pancreatic ductal adenocarcinoma.
Future Oncol
; 17(6): 675-688, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33070660
3.
Innovations in the Management of Hepatocellular Carcinoma.
Am J Ther
; 25(3): e362-e368, 2018.
Article
in English
| MEDLINE | ID: mdl-29561268
4.
Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake.
Fam Cancer
; 22(1): 91-97, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35713757
5.
Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers.
Transl Oncol
; 15(1): 101296, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34847422
6.
Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors.
Front Immunol
; 13: 779691, 2022.
Article
in English
| MEDLINE | ID: mdl-35558065
7.
Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database.
Surgery
; 171(6): 1464-1470, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35115154
8.
Understanding the Clinical Impact of MUC5AC Expression on Pancreatic Ductal Adenocarcinoma.
Cancers (Basel)
; 13(12)2021 Jun 19.
Article
in English
| MEDLINE | ID: mdl-34205412
9.
A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study.
Front Oncol
; 11: 736620, 2021.
Article
in English
| MEDLINE | ID: mdl-34604072
10.
Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer.
Clin Cancer Res
; 27(2): 554-565, 2021 01 15.
Article
in English
| MEDLINE | ID: mdl-33087331
11.
Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma.
Cancers (Basel)
; 13(20)2021 Oct 15.
Article
in English
| MEDLINE | ID: mdl-34680317
12.
Stage I Squamous Cell Carcinoma of the Anus: Is Radiation Therapy Alone Sufficient Treatment?
Cancers (Basel)
; 12(11)2020 Nov 04.
Article
in English
| MEDLINE | ID: mdl-33158062
13.
Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma.
Front Oncol
; 10: 1311, 2020.
Article
in English
| MEDLINE | ID: mdl-32850412
14.
Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review.
J Cancer Res Ther
; 16(4): 950-954, 2020.
Article
in English
| MEDLINE | ID: mdl-32930150
15.
Neoadjuvant-modified FOLFIRINOX vs nab-paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection.
Cancer Med
; 9(13): 4711-4723, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32415696
16.
Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials.
J Clin Med
; 9(4)2020 Apr 15.
Article
in English
| MEDLINE | ID: mdl-32326559
17.
Screening Patients with Esophageal Cancer to Determine Eligibility for Adjuvant Treatment Trials.
Anticancer Res
; 38(9): 5247-5251, 2018 Sep.
Article
in English
| MEDLINE | ID: mdl-30194174
18.
Results of an educational program to promote the use of pooled instead of single-donor platelet transfusions.
Proc (Bayl Univ Med Cent)
; 26(1): 3-5, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23382598
Results
1 -
18
de 18
1
Next >
>>